Gain Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Gain Therapeutics Inc
TickerGANX
CIK #0001819411
CUSIP36269B105
SectorLife Sciences - Pharmaceutical Preparations
Address4800 Hampden Lane Suite 200, Bethesda, MD 20814
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Gain Therapeutics Inc 2020-07-30 10.0 M Exemption: 506(b) · Minimum: $50,000 · Duration: One year or less · Commission: $800,000 · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001819411] 10-K
[0001819411] 10-Q
[0001819411] 3
[0001819411] 4
[0001819411] 8-K
[0001819411] D
Form 3/4/5 Filer 2011 - 2026
Gain Therapeutics Inc
Mack Gene
Fuggetta Gianluca
Islam Khalid
Riley Jeffrey Scott
Hasler Hans Peter
Melincoff Gwen A
Goldstein Dov A MD
Richman Eric I
Nicaise Claude
Alder Matthias
Ballantyne Charles Evan
Calabrese Salvatore
Bellotto Manolo
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Mack Gene
Employee Stock Option (right to buy) · derivative
2026-03-24 Grant 200,000 $0.00
Fuggetta Gianluca
Employee Stock Option (right to buy) · derivative
2026-03-24 Grant 50,000 $0.00
Hasler Hans Peter
Stock Option (right to buy) · derivative
2025-06-24 Grant 15,000 $0.00
Richman Eric I
Stock Option (right to buy) · derivative
2025-06-24 Grant 15,000 $0.00
Nicaise Claude
Stock Option (right to buy) · derivative
2025-06-24 Grant 15,000 $0.00
Islam Khalid
Stock Option (right to buy) · derivative
2025-06-24 Grant 15,000 $0.00
Riley Jeffrey Scott
Stock Option (right to buy) · derivative
2025-06-24 Grant 15,000 $0.00
Goldstein Dov A MD
Stock Option (right to buy) · derivative
2025-06-24 Grant 15,000 $0.00
Melincoff Gwen A
Stock Option (right to buy) · derivative
2025-06-24 Grant 15,000 $0.00
Fuggetta Gianluca
Employee Stock Option (right to buy) · derivative
2025-03-20 Grant 50,000 $0.00
Mack Gene
Employee Stock Option (right to buy) · derivative
2025-03-20 Grant 200,000 $0.00
Mack Gene
Stock Option (right to buy) · derivative
2025-01-06 Grant 271,325 $0.00
Islam Khalid
Common Stock
2024-08-09 Buy 50,000 $1.00 50,000
Mack Gene
Common Stock
2024-08-09 Buy 14,400 $1.01 14,544
Richman Eric I
Common Stock
2024-07-01 Buy 5,000 $1.23 6,150
Richman Eric I
Common Stock
2024-07-01 Buy 12,000 $1.21 14,520
Goldstein Dov A MD
Stock Option (right to buy) · derivative
2024-06-24 Grant 15,000 $0.00
Islam Khalid
Stock Option (right to buy) · derivative
2024-06-24 Grant 15,000 $0.00
Melincoff Gwen A
Stock Option (right to buy) · derivative
2024-06-24 Grant 15,000 $0.00
Hasler Hans Peter
Stock Option (right to buy) · derivative
2024-06-24 Grant 15,000 $0.00
showing 20 of 81 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 42 8,317,799
2025-12-31 49 8,124,796
2025-09-30 38 4,378,242
2025-06-30 36 3,825,759
2025-03-31 34 2,827,790
2024-12-31 26 1,999,926
2024-09-30 21 1,685,173
2024-06-30 29 3,036,881
2024-03-31 27 1,911,415
2023-12-31 25 1,556,547
2023-09-30 25 1,521,323
2023-06-30 25 1,320,222
Form 13F Holdings
Firm Period DFND Voting Shares
Benedict Financial Advisors Inc [2026-06-30] SOLE 35,000 35,000
Oliver Luxxe Assets LLC [2026-06-30] SOLE 0 20,250
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 1,500 17,056
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com